688358 祥生医疗
已收盘 08-06 15:00:01
资讯
新帖
简况
【机构调研记录】恒越基金调研祥生医疗
证券之星 · 07-20
【机构调研记录】恒越基金调研祥生医疗
股市必读：祥生医疗（688358）7月17日披露最新机构调研信息
证券之星 · 07-20
股市必读：祥生医疗（688358）7月17日披露最新机构调研信息
股市必读：祥生医疗（688358）7月16日董秘有最新回复
证券之星 · 07-17
股市必读：祥生医疗（688358）7月16日董秘有最新回复
祥生医疗：乳腺人工智能超声机器人获医疗器械检测报告
证券之星 · 07-16
祥生医疗：乳腺人工智能超声机器人获医疗器械检测报告
祥生医疗（688358）披露2026年限制性股票激励计划首次授予公告，7月9日股价下跌0.77%
证券之星 · 07-09
祥生医疗（688358）披露2026年限制性股票激励计划首次授予公告，7月9日股价下跌0.77%
每周股票复盘：祥生医疗（688358）推2026年限制性股票激励计划
证券之星 · 07-05
每周股票复盘：祥生医疗（688358）推2026年限制性股票激励计划
祥生医疗：公司目前生产经营正常
证券之星 · 07-01
祥生医疗：公司目前生产经营正常
祥生医疗（688358）披露2026年限制性股票激励计划草案，6月30日股价下跌0.49%
证券之星 · 06-30
祥生医疗（688358）披露2026年限制性股票激励计划草案，6月30日股价下跌0.49%
每周股票复盘：祥生医疗（688358）拟推2026年限制性股票激励计划
证券之星 · 06-28
每周股票复盘：祥生医疗（688358）拟推2026年限制性股票激励计划
祥生医疗（688358）披露2026年限制性股票激励计划草案，6月23日股价上涨0.94%
证券之星 · 06-23
祥生医疗（688358）披露2026年限制性股票激励计划草案，6月23日股价上涨0.94%
祥生医疗(688358.SH)拟推2026年限制性股票激励计划
智通财经 · 06-12
祥生医疗(688358.SH)拟推2026年限制性股票激励计划
【机构调研记录】鹏扬基金调研中国核电、祥生医疗等3只个股（附名单）
证券之星 · 05-11
【机构调研记录】鹏扬基金调研中国核电、祥生医疗等3只个股（附名单）
【机构调研记录】凯石基金调研祥生医疗
证券之星 · 05-11
【机构调研记录】凯石基金调研祥生医疗
每周股票复盘：祥生医疗（688358）Q1净利增10.6%
证券之星 · 05-02
每周股票复盘：祥生医疗（688358）Q1净利增10.6%
图解祥生医疗一季报：第一季度单季净利润同比增长10.60%
证券之星 · 04-28
图解祥生医疗一季报：第一季度单季净利润同比增长10.60%
北京微仙医疗召回部分颅内支架系统；礼来拟斥巨资收购一家公司
21世纪经济报道 · 04-21
北京微仙医疗召回部分颅内支架系统；礼来拟斥巨资收购一家公司
祥生医疗(688358.SH)发布2025年度业绩，归母净利润1.16亿元，同比下降17.09%
智通财经 · 04-19
祥生医疗(688358.SH)发布2025年度业绩，归母净利润1.16亿元，同比下降17.09%
祥生医疗(688358)3月31日股东户数0.64万户，较上期增加3.17%
证券之星 · 04-19
祥生医疗(688358)3月31日股东户数0.64万户，较上期增加3.17%
祥生医疗（688358）披露关于变更持续督导保荐代表人的公告，3月30日股价上涨1.2%
证券之星 · 03-30
祥生医疗（688358）披露关于变更持续督导保荐代表人的公告，3月30日股价上涨1.2%
每周股票复盘：祥生医疗（688358）变更持续督导保荐代表人
证券之星 · 03-29
每周股票复盘：祥生医疗（688358）变更持续督导保荐代表人
暂无数据
公司概况
公司名称：
无锡祥生医疗科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2019-12-03
主营业务：
无锡祥生医疗科技股份有限公司的主营业务是超声医学影像设备的研发、制造和销售。公司的主要产品是超声医学影像设备、配件、技术服务。公司产品获得包括中国NMPA、欧盟CE、美国FDA等高标准的市场准入。2025年公司全系产品通过MDR认证，标志着公司产品认证与国际顶尖巨头并轨。
发行价格：
50.53
{"stockData":{"symbol":"688358","market":"SH","secType":"STK","nameCN":"祥生医疗","latestPrice":28.88,"timestamp":1785999601000,"preClose":28.78,"halted":0,"volume":1020877,"delay":0,"changeRate":0.0035,"floatShares":112000000,"shares":112000000,"eps":1.0784,"marketStatus":"已收盘","change":0.1,"latestTime":"08-06 15:00:01","open":28.5,"high":29.24,"low":28.35,"amount":29429100,"amplitude":0.0309,"askPrice":28.88,"askSize":21,"bidPrice":28.87,"bidSize":8,"shortable":0,"etf":0,"ttmEps":1.0784,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786066200000},"marketStatusCode":5,"adr":0,"adjPreClose":28.78,"symbolType":"stock_kcb","openAndCloseTimeList":[[1785979800000,1785987000000],[1785992400000,1785999600000]],"highLimit":31.66,"lowLimit":25.9,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":112125613,"isCdr":false,"pbRate":2.28,"roa":"--","peRate":26.780415,"roe":"3.28%","epsLYR":1.04,"committee":0.284615,"marketValue":3238000000,"turnoverRate":0.0091,"status":0,"afterMarket":{"amount":0,"volume":0,"close":28.88,"buyVolume":600,"sellVolume":0,"time":1786001637746,"indexStatus":"已收盘 08-06 15:30:00","preClose":28.78},"floatMarketCap":3234000000},"requestUrl":"/m/hq/s/688358/tweets","defaultTab":"tweets","newsList":[{"id":"2652268010","title":"【机构调研记录】恒越基金调研祥生医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2652268010","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652268010?lang=zh_cn&edition=full","pubTime":"2026-07-20 08:01","pubTimestamp":1784505706,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及7月17日披露的机构调研信息，恒越基金近期对1家上市公司进行了调研，相关名单如下：1）祥生医疗 调研纪要：公司持续推进全球化布局与I生态战略，海外销售网络覆盖100多个国家，2025年全系列产品通过欧盟MDR认证。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000001865.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652854257","title":"股市必读：祥生医疗（688358）7月17日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2652854257","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652854257?lang=zh_cn&edition=full","pubTime":"2026-07-20 01:57","pubTimestamp":1784483830,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，祥生医疗报收于28.8元，下跌8.8%，换手率2.47%，成交量2.76万手，成交额8191.34万元。机构调研要点：SonoFamily全系列产品已全线搭载SonoI平台，CHISON Pilot全球上线，SonoPort与SonoGo于第93届CMEF发布。分红情况：2025年年度利润分配向全体股东每10股派发现金红利5.80元（含税），合计65,032,855.54元（含税）；叠加2025年前三季度分红33,637,683.90元（含税），全年累计现金分红98,670,539.44元（含税），占当年度归母净利润比例为84.70%；2019年上市以来累计现金分红4.97亿元，超募集资金净额50%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000000953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688358","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652092429","title":"股市必读：祥生医疗（688358）7月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2652092429","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652092429?lang=zh_cn&edition=full","pubTime":"2026-07-17 02:22","pubTimestamp":1784226131,"startTime":"0","endTime":"0","summary":"截至2026年7月16日收盘，祥生医疗报收于31.58元，上涨4.99%，换手率2.3%，成交量2.58万手，成交额8061.97万元。董秘最新回复投资者： 董秘你好，贵公司的六自由度机械臂方案目前进展如何？公司自主研发的“乳腺人工智能超声机器人”已率先获得医疗器械检测报告。这些技术已深度融入“AI+机器人扫查”解决方案，为恶性肿瘤群体性筛查提供创新路径。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700001276.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688358","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651121124","title":"祥生医疗：乳腺人工智能超声机器人获医疗器械检测报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2651121124","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651121124?lang=zh_cn&edition=full","pubTime":"2026-07-16 16:06","pubTimestamp":1784189168,"startTime":"0","endTime":"0","summary":"证券之星消息，祥生医疗07月16日在投资者关系平台上答复投资者关心的问题。公司自主研发的“乳腺人工智能超声机器人”已率先获得医疗器械检测报告。这些技术已深度融入“AI+机器人扫查”解决方案，为恶性肿瘤群体性筛查提供创新路径。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600025706.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","BK0251","688358","BK1583","BK1574","161631","BK1100","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650980978","title":"祥生医疗（688358）披露2026年限制性股票激励计划首次授予公告，7月9日股价下跌0.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650980978","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650980978?lang=zh_cn&edition=full","pubTime":"2026-07-09 22:42","pubTimestamp":1783608136,"startTime":"0","endTime":"0","summary":"截至2026年7月9日收盘，祥生医疗报收于32.41元，较前一交易日下跌0.77%，最新总市值为36.34亿元。近日，祥生医疗披露《关于向2026年限制性股票激励计划激励对象首次授予限制性股票的公告》。本次授予的限制性股票为第二类限制性股票，归属安排分为三期，分别在授予日起12个月、24个月、36个月后归属，比例分别为40%、30%、30%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900042848.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649692838","title":"每周股票复盘：祥生医疗（688358）推2026年限制性股票激励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2649692838","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649692838?lang=zh_cn&edition=full","pubTime":"2026-07-05 03:13","pubTimestamp":1783192391,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，祥生医疗报收于34.68元，较上周的30.0元上涨15.6%。本周，祥生医疗7月1日盘中最高价报36.36元。本次股东会审议通过了2026年限制性股票激励计划（草案）及其摘要、实施考核管理办法、授权董事会办理股权激励相关事宜、制定董事和高级管理人员薪酬管理制度等议案。无锡祥生医疗科技股份有限公司对2026年限制性股票激励计划内幕信息知情人及激励对象在草案公告日前六个月内买卖公司股票的情况进行了自查。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001009.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688358","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648551330","title":"祥生医疗：公司目前生产经营正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2648551330","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648551330?lang=zh_cn&edition=full","pubTime":"2026-07-01 15:36","pubTimestamp":1782891417,"startTime":"0","endTime":"0","summary":"证券之星消息，祥生医疗07月01日在投资者关系平台上答复投资者关心的问题。公司目前生产经营正常，并持续积极开拓市场，努力提升经营业绩，不断提升核心竞争力，促进公司持续健康发展，力争以良好的业绩回报投资者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100024573.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688358","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647384557","title":"祥生医疗（688358）披露2026年限制性股票激励计划草案，6月30日股价下跌0.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647384557","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647384557?lang=zh_cn&edition=full","pubTime":"2026-06-30 22:39","pubTimestamp":1782830357,"startTime":"0","endTime":"0","summary":"截至2026年6月30日收盘，祥生医疗报收于30.57元，较前一交易日下跌0.49%，最新总市值为34.28亿元。该股当日开盘30.52元，最高30.87元，最低30.0元，成交额达2802.6万元，换手率为0.82%。近日，祥生医疗披露《2026年限制性股票激励计划（草案）》及其摘要公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000047345.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688358","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646137543","title":"每周股票复盘：祥生医疗（688358）拟推2026年限制性股票激励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2646137543","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646137543?lang=zh_cn&edition=full","pubTime":"2026-06-28 02:44","pubTimestamp":1782585853,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，祥生医疗报收于30.0元，较上周的32.2元下跌6.83%。本周，祥生医疗6月24日盘中最高价报34.88元。本周关注点公司公告汇总：祥生医疗拟实施2026年限制性股票激励计划，激励对象名单已公示且无异议。公司公告汇总：祥生医疗将于2026年6月30日召开临时股东会，审议股权激励相关议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000725.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688358","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645883297","title":"祥生医疗（688358）披露2026年限制性股票激励计划草案，6月23日股价上涨0.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645883297","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645883297?lang=zh_cn&edition=full","pubTime":"2026-06-23 22:22","pubTimestamp":1782224542,"startTime":"0","endTime":"0","summary":"截至2026年6月23日收盘，祥生医疗报收于33.45元，较前一交易日上涨0.94%，最新总市值为37.51亿元。近日，祥生医疗发布《2026年第一次临时股东会会议资料》，公告显示公司将于2026年6月30日召开第一次临时股东会，审议《2026年限制性股票激励计划（草案）》及其摘要、《2026年限制性股票激励计划实施考核管理办法》、提请股东会授权董事会办理股权激励相关事宜，以及制定董事和高级管理人员薪酬管理制度等议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300042552.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688358","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642935252","title":"祥生医疗(688358.SH)拟推2026年限制性股票激励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2642935252","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2642935252?lang=zh_cn&edition=full","pubTime":"2026-06-12 20:36","pubTimestamp":1781267809,"startTime":"0","endTime":"0","summary":"智通财经APP讯，祥生医疗(688358.SH)披露2026年限制性股票激励计划(草案)，此次激励计划拟向激励对象授予49.75万股限制性股票，约占激励计划草案公告时公司股本总额1.12亿股的0.44%。其中，首次授予39.8万股，预留9.95万股。限制性股票的授予价格(含预留)为17.10元/股。首次授予的激励对象总人数共计35人，约占2025年12月31日公司员工总数的7.49%，激励对象为公告激励计划时在公司(含分公司、子公司)任职的董事会认为需要激励的人员，不包括公司董事、高级管理人员及核心技术人员。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453955.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","688358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634249422","title":"【机构调研记录】鹏扬基金调研中国核电、祥生医疗等3只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2634249422","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2634249422?lang=zh_cn&edition=full","pubTime":"2026-05-11 08:03","pubTimestamp":1778457827,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及5月8日披露的机构调研信息，鹏扬基金近期对3家上市公司进行了调研，相关名单如下：1）中国核电 调研纪要：公司一季度开展7个大修，截至4月30日完成5个，含2个10年大修、1个5年大修和2个日常大修，计划5月起陆续启动其余3个。新能源机制电量结算与差价补偿已全部到位。旗下最近一年表现最佳的公募基金产品为鹏扬数字经济先锋混合A，最新单位净值为1.42，近一年增长110.65%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100002364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0179","LU0516422952.EUR","BK0028","LU0516423091.SGD","BK0196","BK0271","BK0035","LU0516423174.USD","BK0183","BK0201","BK0251","601985","BK0012","688358","LU0516422366.SGD","BK0188","LU0516422440.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634263422","title":"【机构调研记录】凯石基金调研祥生医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2634263422","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2634263422?lang=zh_cn&edition=full","pubTime":"2026-05-11 08:02","pubTimestamp":1778457733,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及5月8日披露的机构调研信息，凯石基金近期对1家上市公司进行了调研，相关名单如下：1）祥生医疗 调研纪要：2025年公司实现营业收入4.36亿元，同比下降7.02%；归母净利润1.16亿元，同比下降17.09%。凯石基金成立于2017年，截至目前，资产管理规模1.45亿元，排名201/212；资产管理规模1.45亿元，排名161/212；管理公募基金数7只，排名158/212；旗下公募基金经理3人，排名160/212。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100002271.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632289736","title":"每周股票复盘：祥生医疗（688358）Q1净利增10.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632289736","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2632289736?lang=zh_cn&edition=full","pubTime":"2026-05-02 05:27","pubTimestamp":1777670832,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，祥生医疗报收于31.36元，较上周的28.88元上涨8.59%。本周，祥生医疗4月30日盘中最高价报31.52元。祥生医疗当前最新总市值35.16亿元，在医疗器械板块市值排名99/129，在两市A股市值排名4308/5200。本周关注点来自业绩披露要点：一季度归母净利润4602.63万元，同比上升10.6%。股本股东变化股东户数变动截至2026年3月31日，公司股东户数为6404.0户，较12月31日增加197.0户，增幅3.17%。户均持股数量由上期的1.81万股下降至1.75万股，户均持股市值为50.93万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200003026.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688358","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630170313","title":"图解祥生医疗一季报：第一季度单季净利润同比增长10.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630170313","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2630170313?lang=zh_cn&edition=full","pubTime":"2026-04-28 04:26","pubTimestamp":1777321571,"startTime":"0","endTime":"0","summary":"证券之星消息，祥生医疗2026年一季报显示，一季度公司主营收入1.27亿元，同比下降0.34%；归母净利润4602.63万元，同比上升10.6%；扣非净利润3391.36万元，同比下降12.76%；负债率9.81%，投资收益23.35万元，财务费用-199.58万元，毛利率61.01%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800012108.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629677098","title":"北京微仙医疗召回部分颅内支架系统；礼来拟斥巨资收购一家公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2629677098","media":"21世纪经济报道","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2629677098?lang=zh_cn&edition=full","pubTime":"2026-04-21 08:30","pubTimestamp":1776731449,"startTime":"0","endTime":"0","summary":"政策动向医疗服务价格项目统一进程提速4月20日，国家医保局在“价格立项惠民生”系列宣传媒体通气会上宣布，全国医疗服务价格项目统一工作提速。目前已印发39批立项指南，第40批检验类指南正公开征求意见，将作为本轮收官批次。此举旨在解决各地项目名称、内涵不统一问题，构建全国统一的医疗服务价格“通用语言”。各地平均已落地约30批指南。下一步将结合反馈组织专家论证，尽快完成全部立项审查。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604213711512921.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604213711512921.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1551013342.USD","LU2264538146.SGD","LU0210536198.USD","LU2168564065.EUR","IE00BFTCPJ56.SGD","LU1988902786.USD","LU2552382132.HKD","LU0058720904.USD","IE00BJJMRX11.SGD","LU2361045086.USD","SG9999001176.USD","LU0320765059.SGD","LU0943347566.SGD","LU2552382215.SGD","LU2360106947.USD","LU2106854487.HKD","LU2271345857.HKD","LU2023250504.SGD","IE0009355771.USD","LU0198837287.USD","BK4516","LU2756315318.SGD","LU2361044865.SGD","LU2168564495.EUR","LU0820561818.USD","LU1064131342.USD","LU1035775433.USD","SG9999015952.SGD","IE00BKPKM429.USD","LU0114720955.EUR","LU2491050071.SGD","LU0820561909.HKD","LU1093756325.SGD","LU0432979614.USD","LU0882574055.USD","LU2750360641.GBP","IE00BK4W5M84.HKD","LU0823434583.USD","LU2602419157.SGD","LU2896262040.SGD","LU2237443382.USD","LU1291159041.SGD","LLYX","600518","LU0256863902.USD","BK4588","IE00BFSS8Q28.SGD","LU2237438978.USD","LU2108987350.USD","SG9999018857.SGD","LU2456880835.USD","LU2087625088.SGD","LU2237443465.HKD","SG9999018865.SGD","SGXZ31699556.SGD","IE00B4R5TH58.HKD","GE","LU1366192091.USD","IE00BJJMRZ35.SGD","LU2756315664.SGD","301290","LU0122379950.USD","LU1868836757.USD","LU0323591593.USD","LU0708995401.HKD","600085","IE0004445239.USD","LU2168564222.USD","IE0005OL40V9.USD","LLY","LU0786609619.USD","LU1868836591.USD","LU2552382058.USD","IE00BJJMRY28.SGD","LU2023250330.USD","LU2023251221.USD","LU2471134796.USD","SG9999014914.USD","LU0109394709.USD","LU1629891620.HKD","LU1868837136.USD","SG9999015986.USD","LU1974910355.USD","LU0061475181.USD","LU0354030438.USD","ELIL","IE0004445015.USD","SG9999017495.SGD","IE00B1BXHZ80.USD","LU0353189680.USD","LU0456855351.SGD","LU1145028129.USD","LU2213496289.HKD","LU0158827948.USD","LU2361044949.HKD","LLYZ","LU2028103732.USD","LU0471298777.SGD","LLII","IE00BJT1NW94.SGD","IE00B1XK9C88.USD","BK4585","LU1323610961.USD","SG9999014906.USD","SGXZ99366536.SGD","IE00BFSS7M15.SGD","LU0889565916.HKD","LU1057294990.SGD","LU0079474960.USD","LU2746668974.SGD","LU1868836914.USD","SG9999001176.SGD","IE0001KFT4U8.USD","LU0689472784.USD","LU1720051108.HKD","SG9999014898.SGD","LU0289739699.SGD","LU0320765992.SGD","LU0256863811.USD","LU2089984988.USD","LU2211815571.USD","LU0882574139.USD","BK4581","ELIS","LU2112291526.USD","LU0158827781.USD","LU2168564149.EUR","LU2265009873.SGD","BK4599","LU1232071149.USD","LU0234572021.USD","BK4534","IE00B7KXQ091.USD","600351","LU2111349929.HKD","LU1267930730.SGD","IE00BN29S564.USD","IE00B2B36J28.USD","SGXZ57979304.SGD","IE0002141913.USD","LU2237443978.SGD","LU1712237335.SGD","LU1548497426.USD","LU2750360997.AUD","LU2324357040.USD","LU2237443622.USD","LU1983299246.USD","LU2357305700.SGD","BK4533","BK4007","LU1989771016.USD","LU0096364046.USD","SGXZ51526630.SGD","LU0006306889.USD","SG9999015945.SGD","LU2468319806.SGD","LU2168563687.JPY","LU0097036916.USD","688358","LU0823416689.USD","LU1023059063.AUD","LU1061106388.HKD","IE00BJLML261.HKD","LU1720051017.SGD","LU1069344957.HKD","LU2089284900.SGD","LU0385154629.USD","LU2236285917.USD","LU0238689110.USD","LU0672654240.SGD","LU0787776722.HKD","LU2471134952.CNY","LU2417539215.USD","LU2237443895.HKD","IE00BKDWB100.SGD","LU2746668461.USD","LU1127390331.HKD","IE00BWXC8680.SGD","LU0133085943.USD","LU0823434740.USD","LU1868837300.USD","LU1280957306.USD","LU1551013425.SGD","LU0417517546.SGD","LU0640476718.USD","LU0266013472.USD","LU2063271972.USD","LU2491050154.USD","MDT","IE00B775H168.HKD","LU0353189763.USD","LU2491049909.HKD","LU0466842654.USD","SGXZ81514606.USD","LU0964807845.USD","LU1093756168.USD","LU0820562030.AUD","GB00BDT5M118.USD","LU2089283258.USD","LU2461242641.AUD","LU2237443549.SGD","LU0225283273.USD","LU0203201768.USD","LU1623119135.USD","SG9999015978.USD","IE00B4JS1V06.HKD","LU0106261372.USD","LU0109391861.USD","LU2462157665.USD","LU0094547139.USD","LU1804176565.USD","LU0316494557.USD","LU0203202063.USD","LU0683600562.USD","LU2471134523.USD","LU0471298694.HKD","LU1814569148.SGD","LU2471134879.HKD","IE00BK4W5L77.USD","SG9999014880.SGD","LU1917777945.USD","SG9999013999.USD","LU0354030511.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628694457","title":"祥生医疗(688358.SH)发布2025年度业绩，归母净利润1.16亿元，同比下降17.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628694457","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2628694457?lang=zh_cn&edition=full","pubTime":"2026-04-19 17:23","pubTimestamp":1776590589,"startTime":"0","endTime":"0","summary":"智通财经APP讯，祥生医疗(688358.SH)披露2025年年度报告，报告期公司实现营收4.36亿元，同比下降7.02%;归母净利润1.16亿元，同比下降17.09%;扣非净利润1.03亿元，同比下降18.94%;基本每股收益1.04元。公司拟向全体股东每10股派发现金红利5.80元(含税)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430349.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"祥生医疗(688358.SH)发布2025年度业绩，归母净利润1.16亿元，同比下降17.09%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628769941","title":"祥生医疗(688358)3月31日股东户数0.64万户，较上期增加3.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628769941","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2628769941?lang=zh_cn&edition=full","pubTime":"2026-04-19 17:04","pubTimestamp":1776589441,"startTime":"0","endTime":"0","summary":"证券之星消息，近日祥生医疗披露，截至2026年3月31日公司股东户数为6404.0户，较12月31日增加197.0户，增幅为3.17%。在医疗器械行业个股中，祥生医疗股东户数低于行业平均水平，截至3月31日，医疗器械行业平均股东户数为2.19万户。从股价来看，2025年12月31日至2026年3月31日，祥生医疗区间跌幅为2.53%，在此期间股东户数增加197.0户，增幅为3.17%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900008111.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688358","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623418315","title":"祥生医疗（688358）披露关于变更持续督导保荐代表人的公告，3月30日股价上涨1.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623418315","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2623418315?lang=zh_cn&edition=full","pubTime":"2026-03-30 17:57","pubTimestamp":1774864623,"startTime":"0","endTime":"0","summary":"截至2026年3月30日收盘，祥生医疗报收于29.49元，较前一交易日上涨1.2%，最新总市值为33.07亿元。该股当日开盘28.53元，最高29.51元，最低28.53元，成交额达2166.36万元，换手率为0.66%。祥生医疗于近日披露《关于变更持续督导保荐代表人的公告》。因原保荐代表人黎慧明先生工作变动，不再担任公司持续督导保荐代表人，国金证券委派胡琳扬女士接替其职务。公司董事会对黎慧明先生在任期间的贡献表示感谢。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000025111.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623332713","title":"每周股票复盘：祥生医疗（688358）变更持续督导保荐代表人","url":"https://stock-news.laohu8.com/highlight/detail?id=2623332713","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2623332713?lang=zh_cn&edition=full","pubTime":"2026-03-29 04:51","pubTimestamp":1774731067,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，祥生医疗报收于29.14元，较上周的29.66元下跌1.75%。本周，祥生医疗3月25日盘中最高价报29.88元。3月23日盘中最低价报27.29元。祥生医疗当前最新总市值32.67亿元，在医疗器械板块市值排名104/129，在两市A股市值排名4391/5191。本周关注点公司公告汇总：祥生医疗变更持续督导保荐代表人，胡琳扬女士接替黎慧明先生职务。公司董事会对黎慧明先生在任期间的贡献表示感谢。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900001217.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688358","BK0251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786053423648,"stockEarnings":[{"period":"1week","weight":0.0833},{"period":"1month","weight":-0.1157},{"period":"3month","weight":-0.1319},{"period":"6month","weight":-0.1698},{"period":"1year","weight":-0.1124},{"period":"ytd","weight":-0.015}],"compareEarnings":[{"period":"1week","weight":0.0251},{"period":"1month","weight":-0.0225},{"period":"3month","weight":-0.0669},{"period":"6month","weight":-0.0406},{"period":"1year","weight":0.0733},{"period":"ytd","weight":-0.0173}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"无锡祥生医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"6404人(较上一季度增加3.17%)","perCapita":"17485股","listingDate":"2019-12-03","address":"江苏省无锡市新吴区长江南路3号","registeredCapital":"11212万元","survey":" 无锡祥生医疗科技股份有限公司的主营业务是超声医学影像设备的研发、制造和销售。公司的主要产品是超声医学影像设备、配件、技术服务。公司产品获得包括中国NMPA、欧盟CE、美国FDA等高标准的市场准入。2025年公司全系产品通过MDR认证，标志着公司产品认证与国际顶尖巨头并轨。","listedPrice":50.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"祥生医疗(688358)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供祥生医疗(688358)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"祥生医疗,688358,祥生医疗股票,祥生医疗股票老虎,祥生医疗股票老虎国际,祥生医疗行情,祥生医疗股票行情,祥生医疗股价,祥生医疗股市,祥生医疗股票价格,祥生医疗股票交易,祥生医疗股票购买,祥生医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"祥生医疗(688358)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供祥生医疗(688358)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}